Pioneering treatment for rare kidney disease

Meet Chloe, a HR Assistant who was diagnosed with Atypical Haemolytic Uraemic Syndrome (aHUS) - a very rare genetic disease which can lead to kidney failure.
Pioneering research led by Newcastle University, and Professor David Kavanagh, has confirmed the effectiveness of the drug Eculizumab in preventing kidney failure for those with aHUS.
This treatment has had a life-changing impact on Chloe’s quality of life, her future, and her hope to start a family.